SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Taki Galanis, Geno J. Merli, Contemporary Treatment of Venous Thromboembolic Disease, Cardiology Clinics, 2015, 33, 1, 49

    CrossRef

  2. 2
    Gualtiero Palareti, How D-dimer assay can be useful in deciding the duration of anticoagulation after venous thromboembolism: a review, Expert Review of Hematology, 2015, 8, 1, 79

    CrossRef

  3. 3
    D. Jiménez, F. Uresandi, Consenso intersociedades español sobre el diagnóstico, estratificación de riesgo y tratamiento de pacientes con tromboembolia pulmonar, Angiología, 2014, 66, 2, 70

    CrossRef

  4. 4
    G. Palareti, B. Cosmi, C. Legnani, E. Antonucci, V. De Micheli, A. Ghirarduzzi, D. Poli, S. Testa, A. Tosetto, V. Pengo, P. Prandoni, D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study, Blood, 2014, 124, 2, 196

    CrossRef

  5. 5
    Elliot J.P. Stephenson, Timothy K. Liem, Duplex imaging of residual venous obstruction to guide duration of therapy for lower extremity deep venous thrombosis, Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2014,

    CrossRef

  6. 6
    C. Kearon, E. A. Akl, Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism, Blood, 2014, 123, 12, 1794

    CrossRef

  7. 7
    Kiara C.S. Zapponi, Bruna M. Mazetto, Luis F. Bittar, Aline Barnabé, Fernanda D. Santiago-Bassora, Erich V. De Paula, Fernanda A. Orsi, Carla F. Franco-Penteado, Nicola Conran, Joyce M. Annichino-Bizzacchi, Increased adhesive properties of neutrophils and inflammatory markers in venous thromboembolism patients with residual vein occlusion and high D-dimer levels, Thrombosis Research, 2014, 133, 5, 736

    CrossRef

  8. 8
    Thomas F. O’Donnell, Marc A. Passman, William A. Marston, William J. Ennis, Michael Dalsing, Robert L. Kistner, Fedor Lurie, Peter K. Henke, Monika L. Gloviczki, Bo G. Eklöf, Julianne Stoughton, Sesadri Raju, Cynthia K. Shortell, Joseph D. Raffetto, Hugo Partsch, Lori C. Pounds, Mary E. Cummings, David L. Gillespie, Robert B. McLafferty, Mohammad Hassan Murad, Thomas W. Wakefield, Peter Gloviczki, Management of venous leg ulcers: Clinical practice guidelines of the Society for Vascular Surgery® and the American Venous Forum, Journal of Vascular Surgery, 2014, 60, 2, 3S

    CrossRef

  9. 9
    Ewa Wypasek, Daniel P. Potaczek, Martine Alhenc-Gelas, Anetta Undas, PROS1 mutations associated with protein S deficiency in Polish patients with residual vein obstruction on rivaroxaban therapy, Thrombosis Research, 2014, 134, 1, 199

    CrossRef

  10. 10
    D. Jiménez, D. Kopecna, J. de Miguel, A. Sueiro, Tromboembolia de pulmón, Medicine - Programa de Formación Médica Continuada Acreditado, 2014, 11, 68, 4051

    CrossRef

  11. 11
    Murali Janakiram, Matthew Sullivan, Marina Shcherba, Shuang Guo, Henny H. Billett, A Systematic Review of the Utility of Residual Vein Obstruction Studies in Primary and Secondary Venous Thrombosis, Thrombosis, 2013, 2013, 1

    CrossRef

  12. 12
    Daniela Poli, Gualtiero Palareti, Assessing recurrence risk following acute venous thromboembolism, Current Opinion in Pulmonary Medicine, 2013, 19, 5, 407

    CrossRef

  13. 13
    Fernando Uresandi, Manuel Monreal, Ferrán García-Bragado, Pere Domenech, Ramón Lecumberri, Pilar Escribano, José Luis Zamorano, Sonia Jiménez, Pedro Ruiz-Artacho, Francisco Lozano, Antonio Romera, David Jiménez, Consenso nacional sobre el diagnóstico, estratificación de riesgo y tratamiento de los pacientes con tromboembolia pulmonar, Archivos de Bronconeumología, 2013, 49, 12, 534

    CrossRef

  14. 14
    Bruce Burnett, Management of Venous Thromboembolism, Primary Care: Clinics in Office Practice, 2013, 40, 1, 73

    CrossRef

  15. 15
    Fernando Uresandi, Manuel Monreal, Ferrán García-Bragado, Pere Domenech, Ramón Lecumberri, Pilar Escribano, José Luis Zamorano, Sonia Jiménez, Pedro Ruiz-Artacho, Francisco Lozano, Antonio Romera, David Jiménez, National Consensus on the Diagnosis, Risk Stratification and Treatment of Patients with Pulmonary Embolism, Archivos de Bronconeumología (English Edition), 2013, 49, 12, 534

    CrossRef

  16. You have free access to this content16
    W. Ageno, F. Dentali, M. P. Donadini, A. Squizzato, Optimal treatment duration of venous thrombosis, Journal of Thrombosis and Haemostasis, 2013, 11,
  17. 17
    P. A. Kyrle, L. Eischer, Predicting the risk of recurrent venous thromboembolism, Hämostaseologie, 2013, 33, 3

    CrossRef

  18. 18
    M. P. Donadini, W. Ageno, E. Antonucci, B. Cosmi, M. J. Kovacs, G. Le Gal, P. Ockelford, D. Poli, P. Prandoni, M. Rodger, G. Saccullo, S. Siragusa, L. Young, M. Bonzini, M. Caprioli, F. Dentali, A. Iorio, J. D. Douketis, Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis, Thrombosis and Haemostasis, 2013, 111, 1, 172

    CrossRef

  19. 19
    J. Thachil, Providing accurate information to patients who develop deep vein thrombosis, Clinical Medicine, 2013, 13, 5, 449

    CrossRef

  20. 20
    José María Calvo Romero, Riesgo de recurrencia en la enfermedad tromboembólica venosa tras suspender la anticoagulación, Medicina Clínica, 2013, 140, 7, 310

    CrossRef

  21. 21
    G. Agnelli, C. Becattini, Risk assessment for recurrence and optimal agents for extended treatment of venous thromboembolism, Hematology, 2013, 2013, 1, 471

    CrossRef

  22. 22
    B. Cosmi, C. Legnani, V. Pengo, A. Ghirarduzzi, S. Testa, D. Poli, D. Prisco, A. Tripodi, G. Palareti, The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs, Thrombosis and Haemostasis, 2013, 109, 3, 510

    CrossRef

  23. 23
    Anetta Undas, Mariola Cieśla-Dul, Tomasz Drążkiewicz, Jerzy Sadowski, Altered fibrin clot properties are associated with residual vein obstruction: Effects of lipoprotein(a) and apolipoprotein(a) isoform, Thrombosis Research, 2012, 130, 3, e184

    CrossRef

  24. 24
    P. A. Kyrle, S. Eichinger, Clinical scores to predict recurrence risk of venous thromboembolism, Thrombosis and Haemostasis, 2012, 108, 6, 1061

    CrossRef

  25. 25
    J J van Middendorp, G Barbagallo, M Schuetz, A J F Hosman, Design and rationale of a Prospective, Observational European Multicenter study on the efficacy of acute surgical decompression after traumatic Spinal Cord Injury: the SCI-POEM study, Spinal Cord, 2012, 50, 9, 686

    CrossRef

  26. 26
    T. BAGLIN, K. BAUER, J. DOUKETIS, H. BULLER, A. SRIVASTAVA, G. JOHNSON, Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH, Journal of Thrombosis and Haemostasis, 2012, 10, 4
  27. 27
    Paulien G. Jong, Michiel Coppens, Saskia Middeldorp, Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term, British Journal of Haematology, 2012, 158, 4
  28. 28
    M. TAN, C. BORNAIS, M. RODGER, Interobserver reliability of compression ultrasound for residual thrombosis after first unprovoked deep vein thrombosis, Journal of Thrombosis and Haemostasis, 2012, 10, 9
  29. 29
    Jong-Woong Byun, Woo-Hyung Kwun, Bo-Yang Suh, Predictor of Recanalization in Lower Extremity Deep Vein Thrombosis, Korean Journal of Vascular and Endovascular Surgery, 2012, 28, 1, 43

    CrossRef

  30. 30
    Jecko Thachil, Recurrent venous thromboembolism while on anticoagulant therapy, Blood Reviews, 2012, 26, 4, 175

    CrossRef

  31. 31
    Gualtiero Palareti, Recurrent Venous Thromboembolism: What Is the Risk and How to Prevent It, Scientifica, 2012, 2012, 1

    CrossRef

  32. 32
    D. Poli, C. Cenci, E. Antonucci, E. Grifoni, C. Arcangeli, D. Prisco, R. Abbate, M. Miniati, Risk of recurrence in patients with pulmonary embolism: Predictive role of D-dimer and of residual perfusion defects on lung scintigraphy, Thrombosis and Haemostasis, 2012, 109, 2, 181

    CrossRef

  33. 33
    Alaa Alhadad, Massimo Miniati, Hussein Alhadad, Anders Gottsäter, Marika Bajc, The value of tomographic ventilation/perfusion scintigraphy (V/PSPECT) for follow-up and prediction of recurrence in pulmonary embolism, Thrombosis Research, 2012, 130, 6, 877

    CrossRef

  34. 34
    Sergio Siragusa, Alessandra Malato, Giorgia Saccullo, Alfonso Iorio, Mauro Di Ianni, Clementina Caracciolo, Lucio Lo Coco, Simona Raso, Marco Santoro, Francesco Paolo Guarneri, Antonino Tuttolomondo, Antonio Pinto, Iliana Pepe, Alessandra Casuccio, Vincenzo Abbadessa, Giuseppe Licata, Giovan Battista Rini, Guglielmo Mariani, Gaetana Di Fede, Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study, American Journal of Hematology, 2011, 86, 11
  35. 35
    H. G. WATSON, RVO – Real value obscure, Journal of Thrombosis and Haemostasis, 2011, 9, 6
  36. 36
    Marcello Di Nisio, Harry R. Büller, Antithrombotic Therapy in Venous Thrombosis and Pulmonary Embolism,